Penneco In The News
Penneco Oil and Drilling is dedicated to nourishing and growing the natural gas and crude oil industry in innovative and environmentally friendly ways. Since our incorporation in 1979, by showing our initiative towards using multi-well pads, which reduce the negative impact of drilling on the environment, to teaming up with GEODynamics to help deliver clean fractured tunnel tips we have made the news several times.
Read about our eco-friendly advancements over the past few years below.
News Articles and Press Releases
Penneco Oil and Drilling Associates Utilizes Multi-Well Pads To Reduce Impact On The Environment – PRWeb (November 13, 2012)
PENNECO Teams Up with GEODynamics to Apply Connex – Press Release Point (March 22, 2010)
City Gas Well No Sure Thing, Drillers Say – The Tube City Almanac (October 31, 2010)
Outside Scholarship Opportunities in the Energy Industry
In 2013, Penneco announced to the public that it would be introducing an outside scholarship program titled Penneco Invests in the Future of Energy. The program is geared towards a future of innovative and efficient energy. Penneco’s scholarship program offered $2,000 to two college students technical majors like geology, chemical and mechanical engineering, and petroleum engineering.
Below are news sites that announced the Penneco Invests in the Future of Energy Scholarship Program.
Penneco Announces Scholarship Program: Penneco Invests in the Future of Energy – Market Watch (November 21, 2013)
Penneco Announces Scholarship Program: Penneco Invests in the Future of Energy – Market Wired (November 21, 2013)
Penneco Announces Scholarship Program: Penneco Invests in the Future of Energy – Yahoo Finance (November 21, 2013)
Penneco, Investing in America’s Future – SlideShare (June 28, 2013)
- Got Guts? Buy Nio Stock at This Super-High Valuation
- Biden Vs. Trump: Here's what to expect in the markets once 2020 election is decided
- Pfizer CEO says coronavirus vaccine could be ready by late November
- California’s Boom Collapses as Fires Add $1.1 Billion Toll
- Gloomy COVID drug data shows why big, randomised trials matter